The Federal Register

Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget

Wed, Dec 14 2005 11:00:00 GMT

Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget

Wed, Dec 14 2005 11:00:00 GMT

Guidance for Industry and Food and Drug Administration; Requesting an Extension to Use Existing Label Stock After the

Wed, Dec 14 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled, ``Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006.'' The trans fat final rule published in the Federal Register on July 11, 2003. This guidance document provides guidance to FDA and the food industry about when and how businesses may request the agency to consider enforcement discretion for the use, on products introduced into interstate commerce on or after the January 1, 2006, effective date, of some or all existing label stock that does not declare trans fat labeling in compliance with the final rule.

Tribal Self-Governance Program Planning Cooperative Agreement; New Funding Cycle for Fiscal Year 2006

Wed, Dec 14 2005 11:00:00 GMT

Key Dates: Applications DueJanuary 20, 2006; Objective Review Committee to Evaluate ApplicationsMarch 89, 2006; Anticipated Project Start DateApril 1 , 2006.

I. Funding Opportunity Description

The purpose of the program is to award cooperative agreements that provide planning resources to Tribes interested in participating in the Tribal SelfGovernance Program (TSGP) as authorized by Title V, Tribal SelfGovernance Amendments of 2000 of the Indian SelfDetermination and Education Assistance Act of Public Law (Pub. L.) 93638, as amended. The TSGP is designed to promote selfdetermination by allowing Tribes to assume more control of Indian Health Service (IHS) programs and services through compacts negotiated with the IHS. The Planning Cooperative
[[Page 74021]]
Agreement allows a Tribe to gather information to determine the current types and amounts of Programs, Services, Functions, and Activities (PSFAs), and funding available at the Service Unit, Area, and Headquarters levels and identify p

Clinical Center; Notice of Meeting

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the NIH Advisory Board for Clinical Research.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set froth in section 552b(c)(6), Title 5 U.S.C., as amended for discussion of personal qualifications and performance, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: NIH Advisory Board for Clinical Research.

Date: January 30, 2006.

Open: 10 a.m. to 1:30 p.m.

To review the Clinical Center operating plan, ABCR workgroups and Budgetary issues.

Nati

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Genomics of Transplantation Cooperative Research Program.

Date: December 1921, 2005.

Time: 6 p.m. to 4 p.m.

Agenda: To review and evaluate cooperative agreement applications.

Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

Contact Person: Q

National Institute of Diabetes and Digestive and Kidney Diseases, Notice of Closed Meeting

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Liver Injury and Repopulation by Bone Marrow Stem Cells.

Date: February 7, 2006.

Time: 2 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20

National Institute of Mental Health; Notice of Closed Meeting

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel, SBIR Phase 1 Contracts Topics 053 and 056.

Date: January 5, 2006.

Time: 12 p.m. to 4 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact

National Institute of Mental Health; Notice of Closed Meetings

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel, TimeSensitive Research.

Date: January 3, 2006.

Time: 4 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20952, (Telephone Conference Call).

Contact Person: Aileen Sc

National Institute on Drug Abuse; Notice of Closed Meeting

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel NIDAK Teleconference Meeting.

Date: December 22, 2005.

Time: 10 a.m. to 11:30 a.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Eliane LazarWesley, PhD,

Center for Scientific Review; Notice of Closed Meetings

Wed, Dec 14 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Hematopoietic Stem Cells.

Date: December 19, 2005.

Time: 1:30 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Delia Tang, MD, Scientific Review Ad

National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Extension of the

Wed, Dec 14 2005 11:00:00 GMT

The CERHR announces a 30-day extension of the public comment period on the DEHP update expert panel report. The CERHR previously announced a public comment period on the DEHP update expert panel report in a prior Federal Register Notice [November 16, 2005 (Vol. 70, No. 220, pg. 69567)]. The DEHP update expert panel report was released by CERHR on November 21, 2005 and public comments will now be accepted by CERHR through Friday, February 3, 2006 instead of the original deadline of January 4, 2006. The DEHP update expert panel report is available from the CERHR Web site (http://cerhr.niehs.nih.gov) or in print from the CERHR (see ADDRESSES below).